Infinity Pharmaceuticals, Inc.
INFIQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -40.95M | -42.98M | -44.37M | -46.79M | -46.79M |
| Total Depreciation and Amortization | 428.00K | 442.00K | 458.00K | 472.00K | 482.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.19M | 3.15M | 2.52M | 2.38M | 2.28M |
| Change in Net Operating Assets | -1.56M | -2.09M | -1.04M | 690.00K | 2.31M |
| Cash from Operations | -38.88M | -41.47M | -42.43M | -43.25M | -41.71M |
| Capital Expenditure | 0.00 | 0.00 | -17.00K | -17.00K | -28.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.73M | 14.01M | -38.00K | -38.00K | -10.77M |
| Cash from Investing | 10.73M | 14.01M | -55.00K | -55.00K | -10.80M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 61.00K | 73.00K | 73.00K | 398.00K | 930.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 61.00K | 73.00K | 73.00K | 398.00K | 930.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.09M | -27.39M | -42.41M | -42.91M | -51.58M |